Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome (DefeHEMY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01892644
Recruitment Status : Terminated (Failure to recruit patients with hemochromatosis to the Deferasirox arm)
First Posted : July 4, 2013
Last Update Posted : January 23, 2017
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Haukeland University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017
Publications: